[go: up one dir, main page]

AU2001271502A1 - Methods and compositions for isolating biologically active antibodies - Google Patents

Methods and compositions for isolating biologically active antibodies

Info

Publication number
AU2001271502A1
AU2001271502A1 AU2001271502A AU7150201A AU2001271502A1 AU 2001271502 A1 AU2001271502 A1 AU 2001271502A1 AU 2001271502 A AU2001271502 A AU 2001271502A AU 7150201 A AU7150201 A AU 7150201A AU 2001271502 A1 AU2001271502 A1 AU 2001271502A1
Authority
AU
Australia
Prior art keywords
compositions
methods
biologically active
active antibodies
isolating biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271502A
Inventor
Jeno Gyuris
Sebastian Meier-Ewert
Aaron Morris
Zoltan Nagy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agennix AG
Agennix USA Inc
Original Assignee
GPC Biotech AG
GPC Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GPC Biotech AG, GPC Biotech Inc filed Critical GPC Biotech AG
Publication of AU2001271502A1 publication Critical patent/AU2001271502A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001271502A 2000-06-26 2001-06-26 Methods and compositions for isolating biologically active antibodies Abandoned AU2001271502A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21420000P 2000-06-26 2000-06-26
US60/214,200 2000-06-26
PCT/US2001/020380 WO2002000728A2 (en) 2000-06-26 2001-06-26 Methods and compositions for isolating biologically active antibodies

Publications (1)

Publication Number Publication Date
AU2001271502A1 true AU2001271502A1 (en) 2002-01-08

Family

ID=22798184

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271502A Abandoned AU2001271502A1 (en) 2000-06-26 2001-06-26 Methods and compositions for isolating biologically active antibodies

Country Status (3)

Country Link
US (1) US20020025536A1 (en)
AU (1) AU2001271502A1 (en)
WO (1) WO2002000728A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
WO2003035842A2 (en) * 2001-10-24 2003-05-01 Dyax Corporation Hybridization control of sequence variation
US7253007B2 (en) * 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7413866B2 (en) 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7871619B2 (en) * 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7244592B2 (en) 2002-03-07 2007-07-17 Dyax Corp. Ligand screening and discovery
AU2003250518A1 (en) * 2002-08-20 2004-03-11 Yeda Research And Development Co. Ltd. Akap84 and its use for visualization of biological structures
EP1606251B1 (en) * 2002-12-20 2009-04-08 ChemoCentryx Inc Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
CA2528549A1 (en) * 2003-06-06 2005-06-02 Medimmune, Inc. Use of epha4 and modulator of epha4 for diagnosis, treatment and prevention of cancer
US20100247540A1 (en) * 2003-10-30 2010-09-30 Chemocentryx, Inc. Methods and Compositions For Modulating Angiogenesis
MX2007013108A (en) * 2005-04-21 2008-04-07 Chemocentryx Inc Reagents that bind ccx-ckr2.
AU2006255536A1 (en) * 2005-06-03 2006-12-14 Novartis Vaccines And Diagnostics Inc. Methods of treating, diagnosing or detecting cancer using an EphB3 modulator
EP1963494B1 (en) * 2005-11-29 2014-10-08 The Trustees of The University of Pennsylvania Phage particle diagnostic reagents
US8067179B2 (en) 2006-11-30 2011-11-29 Research Development Foundation Immunoglobulin libraries
KR101561416B1 (en) 2007-08-30 2015-10-16 다이이찌 산쿄 가부시키가이샤 Anti-epha2 antibody
US20130338038A1 (en) 2007-12-21 2013-12-19 Pdl Biopharma, Inc. Method of screening complex protein libraries to identify altered properties
CA2760153A1 (en) * 2009-04-27 2010-11-11 Alex Chenchik Reagents and methods for producing bioactive secreted peptides
WO2016117541A1 (en) * 2015-01-22 2016-07-28 株式会社村田製作所 Void array structure and method for producing same
CN107266580B (en) * 2017-05-26 2020-12-11 上海交通大学 An optimized target capture system based on bacterial cell surface display system
US11275082B2 (en) * 2020-03-09 2022-03-15 National Taipei University Of Technology Methods of detection of compound, antibody or protein using recombinant endospores or bacteria as sensing element

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015982A2 (en) * 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies

Also Published As

Publication number Publication date
WO2002000728A3 (en) 2003-01-03
WO2002000728A2 (en) 2002-01-03
US20020025536A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001271502A1 (en) Methods and compositions for isolating biologically active antibodies
AU2002243277A1 (en) Methods and compositions for encapsulating active agents
AU2001261566A1 (en) Well service composition and method
AUPQ419099A0 (en) Novel compositions and methods
AUPQ879000A0 (en) Mortar composition and method
AU3933200A (en) Compositions and methods for controlling pests
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2002354929A1 (en) Antibodies specific for nanotubes and related methods and compositions
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002222170A1 (en) Method and system for icosaborane implantation
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU3240000A (en) Hydrophobic and particulate soil removal composition
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001275007A1 (en) Methods of testing materials
AU2001233932A1 (en) Method and composition
AU2001236718A1 (en) Bioreactor and related method
AU2002245510A1 (en) Method and composition for embalming
AU2002248247A1 (en) Method and compositions for attracting mosquitoes
AU2002239775A1 (en) Chemical-library composition and method
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU2001276928A1 (en) Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
AU2001250585A1 (en) Insecticidal peptides and methods for using same
AU1477601A (en) Genetic compositions and methods